Category: Life Sciences
Global Life Sciences
-
Surgical Robots
... CAGR of 10.0% over the analysis period 2024-2030. Instruments & Accessories, one of the segments analyzed in the report, is expected to record a 11.2% CAGR and reach US$7.9 Billion by the end of the ... Read More
-
Spine Biologics
... CAGR of 4.4% over the analysis period 2024-2030. Spinal Allografts, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.4 Billion by the end of the analysis ... Read More
-
Stem Cell Assays
... at a CAGR of 17.9% over the analysis period 2024-2030. Instruments Component, one of the segments analyzed in the report, is expected to record a 18.4% CAGR and reach US$6.1 Billion by the end of ... Read More
-
Sterility Testing
... CAGR of 10.9% over the analysis period 2024-2030. Sterility Testing Kits & Reagents, one of the segments analyzed in the report, is expected to record a 12.2% CAGR and reach US$184.9 Million by the end ... Read More
-
Superdisintegrants
... 5.4% over the analysis period 2024-2030. Synthetic Superdisintegrants, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$262.2 Million by the end of the analysis period. Growth ... Read More
-
Surgical Staplers
... CAGR of 5.0% over the analysis period 2024-2030. Manual Staplers, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$4.6 Billion by the end of the analysis ... Read More
-
Pyrogen Testing
... CAGR of 10.4% over the analysis period 2024-2030. Pyrogen Testing Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$1.1 Billion by the ... Read More
-
Sample Preparation
... CAGR of 4.6% over the analysis period 2024-2030. Sample Preparation Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$4.5 Billion by the end of the ... Read More
-
Agricultural Biotechnology
... CAGR of 9.2% over the analysis period 2024-2030. Molecular Diagnostics, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$39.0 Billion by the end of the analysis ... Read More
-
Anticoagulants
... 9.2% over the analysis period 2024-2030. NOACs, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis period. Growth in ... Read More
-
Nuclear Medicine Imaging Equipment
... 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. Single-Photon Emission Computed Tomography (SPECT) Systems, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach ... Read More
-
Machine Vision Systems
... at a CAGR of 4.1% over the analysis period 2024-2030. Machine Vision Hardware, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$8.1 Billion by the end ... Read More
-
Alopecia Drugs
... CAGR of 5.5% over the analysis period 2024-2030. Topical Drugs, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$8.4 Billion by the end of the analysis ... Read More
-
Analytical Laboratory Services
... at a CAGR of 9.0% over the analysis period 2024-2030. Bioanalytical Testing Services, one of the segments analyzed in the report, is expected to record a 9.5% CAGR and reach US$273.4 Million by the end ... Read More
-
Anesthesia Monitoring Devices
... at a CAGR of 8.4% over the analysis period 2024-2030. Advanced Anesthesia Monitors, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$1.6 Billion by the end ... Read More
-
Angioplasty Balloons
... CAGR of 3.9% over the analysis period 2024-2030. Normal Balloons, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$2.1 Billion by the end of the analysis ... Read More
-
Aseptic Sampling
... CAGR of 10.1% over the analysis period 2024-2030. Manual Aseptic Sampling, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$357.4 Million by the end of the ... Read More
-
Autoimmune Disease Diagnosis
... at a CAGR of 6.0% over the analysis period 2024-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$4.1 Billion by the ... Read More
-
Automotive Paints
... CAGR of 2.6% over the analysis period 2024-2030. Clearcoat, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$1.9 Billion by the end of the analysis period. ... Read More
-
Bio-MEMS Devices
... CAGR of 16.7% over the analysis period 2024-2030. Implantables, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$18.2 Billion by the end of the analysis period. ... Read More
-
Blood Screening
... CAGR of 5.5% over the analysis period 2024-2030. Blood Screening Reagents & Kits, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.7 Billion by the end ... Read More
-
Bread Improvers
... CAGR of 4.6% over the analysis period 2024-2030. Powder Form, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$3.6 Billion by the end of the analysis ... Read More
-
Brewing Enzymes
... CAGR of 5.7% over the analysis period 2024-2030. Amylase, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$271.7 Million by the end of the analysis period. ... Read More
-
Burn Care
... CAGR of 3.9% over the analysis period 2024-2030. Advanced Burn Care, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.5 Billion by the end of the ... Read More
-
Cancer Diagnostics
... CAGR of 5.8% over the analysis period 2024-2030. Imaging, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$95.3 Billion by the end of the analysis period. ... Read More
Research Assistance
